CANVAC CCI VACCINE

Country: অস্ট্রেলিয়া

ভাষা: ইংরেজি

সূত্র: APVMA (Australian Pesticides and Veterinary Medicines Authority)

সক্রিয় উপাদান:

BORDETELLA BRONCHISEPTICA (INACTIVATED CELL FREE EXTRACT

থেকে পাওয়া:

ZOETIS AUSTRALIA PTY LTD

INN (International Name):

vaccine - canine Bordetella(7.5ug/mL)

ফার্মাসিউটিকাল ফর্ম:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

রচনা:

BORDETELLA BRONCHISEPTICA (INACTIVATED CELL FREE EXTRACT VACCINE-MICROBIAL Active 7.5 ug/ml

প্যাকেজ ইউনিট:

!20 x 1mL; !Syringe; #100x1mL; #vials; ^20 x 1mL; ^dose vial; 25 x 1 mL; 25 x 1mL

শ্রেণী:

VM - Veterinary Medicine

Manufactured by:

ZOETIS AUSTRALIA

Therapeutic group:

DOG | BITCH | CASTRATE | PUPPY

Therapeutic area:

IMMUNOTHERAPY

থেরাপিউটিক ইঙ্গিত:

BORDETELLA BRONCHISEPTICA | KENNEL COUGH | CANINE COUGH SYNDROME | INFECTIOUS TRACHEOBRONCHITIS

পণ্য সারাংশ:

Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [BORDETELLA BRONCHISEPTICA, KENNEL COUGH]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [BORDETELLA BRONCHISEPTICA, KENNEL COUGH]; For the immunisation of dogs as an aid in the prevention of Bordetella bronchiseptica infection, a contributing factor to the canine cough syndrome.This product should not be used in dogs when they are: incubating an infectious disease; seriously debilitated by another infectious disease, parasitic infection or malnutrition; or under treatment with immunosuppressive drugs. See also SIDE EFFECTS.

অনুমোদন অবস্থা:

Registered

অনুমোদন তারিখ:

2023-07-01

তথ্য লিফলেট

APPENDIX 2
AUSTRALIAN
GOVERNMENT
AUSTRALIAN PESTICIDES AND
VETERINARY MEDICINES AUTHORITY
TEMPLATE FOR RELEVANT LABEL PARTICULARS (RI..PS)
(VETERINARY PRODUCTS)
Select appropriate:
D
New Product (include
all
applicable RLPs)
OR
l!'l
Variation (highlight instructions that
are
being varied). Approval
no.
of lat,el being varied: 55685/54867.
Signal
heading:
Product
name:
Active
constituent/s:
Statement
of
claims:
+
RLP
ApprnvP<'
Net
contents:
DIRECTIONS
FOR
USE
Heading:
Restraints:
Contraindications:
PRECAUTIONS:
Side
effects:
FOR ANIMAL TREATMENT ONLY
CANVAC® CCI VACCINE
Canvac CCi Vaccine is
an
inactivated vaccine prep" red from a cell-free extract of
Bordetefla bronchiseptica
(7.5
~g/ml).
It
is
adjuvanted with
an
immunostimulating
complex to enhance the response
to
vaccination and
to
increase the duration of
immunity.
Canvac CCi Vaccine is used for the immunisation of dogs as
an
aid in the prevention
of
Bordetella bronchiseptica
infection, a contributing factor to the canine cough
syndrome.
The vaccine
is
intended for
the
immunisation
of
dogs against colonization of the upper
and lower respiratory tract
and
the nose and throat with
Bordetella bronchiseptica.
It
may be given alone or used
as
a diluent for other vaccines
in
the Canvac® range. For
optimal effect
on
the incidence and transmission of infectious tracheobronchitis
(canine cough) vaccination with a multicomponent vaccine containing
canine
distemper virus, canine parainfluenza virus and canine adenovirus type
2
is
recommended.
20
x 1
ml
Dose Vials,
20
x 1
ml
Dose Syringes
1
00 x 1
ml
Dose Vials
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE
Contents must
be
left
in
outer package until immediately before use.
Shake gently before use.
N/A
N/A
This product should not
be
used in dogs when they are:
1.
incubating
an
infectious disease;
2.
seriously debilitated
by
another infectious disease,
parasitic infestation or
malnutrition;
or
3.
under treatment with immunosuppressive drugs.
As
Canvac
CCi
Vaccine is
an
inactivated vaccine,
untowa

পণ্য বৈশিষ্ট্য

PRODUCT NAME: CANVAC® CCI VACCINE
PAGE: 1 OF 4
THIS REVISION ISSUED: OCTOBER, 2015
MATERIAL SAFETY DATA SHEET
Issued by: Zoetis Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
ZOETIS AUSTRALIA PTY LTD
ABN 94 156 476 425
Level 6, 5 Rider Blvd
Rhodes NSW 2138 AUSTRALIA
Tel: [phone]
Fax: [phone]
Email: [e-mail]
CHEMICAL NATURE:
Bacterial cell extracts and other ingredients in buffered saline
suspension.
TRADE NAME:
CANVAC
® CCI VACCINE
OTHER NAMES:
_Bordetella bronchiseptica_ Vaccine
PRODUCT USE:
For vaccination by injection of dogs against _Bordetella
bronchiseptica_ (canine cough).
CREATION DATE:
JULY, 2006
THIS VERSION ISSUED:
OCTOBER, 2015
and is valid until August, 2016.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSMP CLASSIFICATION:
None allocated (Aust), S2 (NZ).
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated.
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: White aqueous suspension.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
No significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that this
product is not harmful. In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. I